CLINICAL_TRIALS
trial_result
· 2007-01-01
Clinical Trial Update: Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain. [Phase 3]
Summary
Pfizer completed a Phase 3 study assessing the long-term safety and efficacy of pregabalin in adults with chronic neuropathic pain.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Pain | Phase 3 | Status: COMPLETED